IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v7y2016i1d10.1038_ncomms11150.html
   My bibliography  Save this article

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1

Author

Listed:
  • Chi Lam Au Yeung

    (The University of Texas MD Anderson Cancer Center)

  • Ngai-Na Co

    (The University of Texas MD Anderson Cancer Center)

  • Tetsushi Tsuruga

    (The University of Texas MD Anderson Cancer Center)

  • Tsz-Lun Yeung

    (The University of Texas MD Anderson Cancer Center)

  • Suet-Ying Kwan

    (The University of Texas MD Anderson Cancer Center)

  • Cecilia S. Leung

    (The University of Texas MD Anderson Cancer Center)

  • Yong Li

    (University of Louisville)

  • Edward S. Lu

    (The University of Texas MD Anderson Cancer Center)

  • Kenny Kwan

    (The University of Texas MD Anderson Cancer Center)

  • Kwong-Kwok Wong

    (The University of Texas MD Anderson Cancer Center)

  • Rosemarie Schmandt

    (The University of Texas MD Anderson Cancer Center)

  • Karen H. Lu

    (The University of Texas MD Anderson Cancer Center)

  • Samuel C. Mok

    (The University of Texas MD Anderson Cancer Center)

Abstract

Advanced ovarian cancer usually spreads to the visceral adipose tissue of the omentum. However, the omental stromal cell-derived molecular determinants that modulate ovarian cancer growth have not been characterized. Here, using next-generation sequencing technology, we identify significantly higher levels of microRNA-21 (miR21) isomiRNAs in exosomes and tissue lysates isolated from cancer-associated adipocytes (CAAs) and fibroblasts (CAFs) than in those from ovarian cancer cells. Functional studies reveal that miR21 is transferred from CAAs or CAFs to the cancer cells, where it suppresses ovarian cancer apoptosis and confers chemoresistance by binding to its direct novel target, APAF1. These data suggest that the malignant phenotype of metastatic ovarian cancer cells can be altered by miR21 delivered by exosomes derived from neighbouring stromal cells in the omental tumour microenvironment, and that inhibiting the transfer of stromal-derived miR21 is an alternative modality in the treatment of metastatic and recurrent ovarian cancer.

Suggested Citation

  • Chi Lam Au Yeung & Ngai-Na Co & Tetsushi Tsuruga & Tsz-Lun Yeung & Suet-Ying Kwan & Cecilia S. Leung & Yong Li & Edward S. Lu & Kenny Kwan & Kwong-Kwok Wong & Rosemarie Schmandt & Karen H. Lu & Samuel, 2016. "Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1," Nature Communications, Nature, vol. 7(1), pages 1-14, September.
  • Handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11150
    DOI: 10.1038/ncomms11150
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms11150
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/ncomms11150?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Ao Fang & Yifan Wang & Naiyu Guan & Yanming Zuo & Lingmin Lin & Binjie Guo & Aisheng Mo & Yile Wu & Xurong Lin & Wanxiong Cai & Xiangfeng Chen & Jingjia Ye & Zeinab Abdelrahman & Xiaodan Li & Hanyu Zh, 2023. "Porous microneedle patch with sustained delivery of extracellular vesicles mitigates severe spinal cord injury," Nature Communications, Nature, vol. 14(1), pages 1-17, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11150. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.